Page last updated: 2024-08-23

paroxetine and Acquired Immune Deficiency Syndrome

paroxetine has been researched along with Acquired Immune Deficiency Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engle, EL; Graham, DR; Liu, J; Mankowski, JL; Meulendyke, KA; Nath, A; Queen, SE; Shirk, EN; Steiner, JP; Tarwater, PM; Zink, MC	1
Charness, WE; Ferrando, SJ; Goldman, JD	1
Bergam, K; Claypoole, K; Elliott, AJ; Roy-Byrne, PP; Russo, J; Uldall, KK	1

Trials

2 trial(s) available for paroxetine and Acquired Immune Deficiency Syndrome

Article	Year
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms. General hospital psychiatry, 1997, Volume: 19, Issue:2 Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders	1997
Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. The American journal of psychiatry, 1998, Volume: 155, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Ambulatory Care; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Imipramine; Male; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1998

Article

Year

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

General hospital psychiatry, 1997, Volume: 19, Issue:2

Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders

1997

Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

The American journal of psychiatry, 1998, Volume: 155, Issue:3

Topics: Acquired Immunodeficiency Syndrome; Adult; Ambulatory Care; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Imipramine; Male; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1998

Other Studies

1 other study(ies) available for paroxetine and Acquired Immune Deficiency Syndrome

Article	Year
Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. Journal of neurovirology, 2014, Volume: 20, Issue:6 Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Amyloid beta-Protein Precursor; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Fluconazole; Gene Expression; Humans; Macaca nemestrina; Neurofilament Proteins; Neurons; Nootropic Agents; Paroxetine; Primary Cell Culture; Rats; Selective Serotonin Reuptake Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load; Virus Replication	2014

Article

Year

Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.

Journal of neurovirology, 2014, Volume: 20, Issue:6

Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Amyloid beta-Protein Precursor; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Fluconazole; Gene Expression; Humans; Macaca nemestrina; Neurofilament Proteins; Neurons; Nootropic Agents; Paroxetine; Primary Cell Culture; Rats; Selective Serotonin Reuptake Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load; Virus Replication

2014